| scholarly article | Q13442814 |
| P356 | DOI | 10.1177/0269881106060770 |
| P698 | PubMed publication ID | 16401653 |
| P2093 | author name string | Bradshaw CM | |
| Szabadi E | |||
| Langley RW | |||
| Hou RH | |||
| Samuels ER | |||
| P2860 | cites work | A double-blind, placebo-controlled investigation of the efficacy of modafinil for sustaining the alertness and performance of aviators: a helicopter simulator study | Q48716803 |
| Does short-term treatment with modafinil affect blood pressure in patients with obstructive sleep apnea? | Q48768869 | ||
| Effect of modafinil on plasma melatonin, cortisol and growth hormone rhythms, rectal temperature and performance in healthy subjects during a 36 h sleep deprivation | Q48792734 | ||
| The action of sedatives on brain stem oculomotor systems in man | Q48841867 | ||
| Effects of clonidine and diazepam on the acoustic startle response and on its inhibition by 'prepulses' in man. | Q50511752 | ||
| The projections of the ventral tegmental area and adjacent regions: a combined fluorescent retrograde tracer and immunofluorescence study in the rat. | Q50933545 | ||
| An immunohistochemical study of the organization of catecholaminergic cells and terminal fields in the paraventricular and supraoptic nuclei of the hypothalamus | Q50940143 | ||
| Steady-state pharmacokinetic properties of pramipexole in healthy volunteers | Q50948704 | ||
| Comparison of the antidepressants reboxetine, fluvoxamine and amitriptyline upon spontaneous pupillary fluctuations in healthy human volunteers | Q51081155 | ||
| Pramipexole vs levodopa as initial treatment for Parkinson disease: A randomized controlled trial. Parkinson Study Group. | Q51375126 | ||
| Comparison of the effects of high ambient temperature and clonidine on autonomic functions in man. | Q53938249 | ||
| Randomized trial of modafinil for the treatment of pathological somnolence in narcolepsy | Q56057681 | ||
| Efficacy and safety of modafinil (Provigil) for the treatment of fatigue in multiple sclerosis: a two centre phase 2 study | Q24672427 | ||
| Modafinil improves alertness, vigilance, and executive function during simulated night shifts | Q25930462 | ||
| Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. I. A multivariate analysis of the binding profiles of 14 drugs at 21 native and cloned human receptor subtypes | Q28208581 | ||
| Pramipexole-induced somnolence and episodes of daytime sleep | Q31422765 | ||
| Mathematical procedures in data recording and processing of pupillary fatigue waves | Q31984554 | ||
| Neuroendocrine control of growth hormone secretion | Q33604638 | ||
| Modafinil, d-amphetamine and placebo during 64 hours of sustained mental work. I. Effects on mood, fatigue, cognitive performance and body temperature | Q33884363 | ||
| Cognitive enhancing effects of modafinil in healthy volunteers | Q33962269 | ||
| Treatment of excessive daytime sleepiness in patients with Parkinson's disease with modafinil | Q34125958 | ||
| Modafinil reduces excessive somnolence and enhances mood in patients with myotonic dystrophy | Q34166818 | ||
| Clinical pharmacokinetic profile of modafinil | Q34171699 | ||
| Modafinil treatment of opioid-induced sedation | Q34215840 | ||
| Wake-promoting agents with different mechanisms of action: comparison of effects of modafinil and amphetamine on food intake and cardiovascular activity | Q34304241 | ||
| Modafinil in the treatment of excessive daytime sleepiness in children | Q35579711 | ||
| Involvement of brain catecholamines and acetylcholine in growth hormone deficiency states. Pathophysiological, diagnostic and therapeutic implications | Q36650736 | ||
| Pramipexole in routine clinical practice: a prospective observational trial in Parkinson's disease | Q39389371 | ||
| Acute behavioral and physiological effects of modafinil in drug abusers | Q40643728 | ||
| Role of dopamine in the regulation of growth hormone secretion: dopamine and bromocriptine augment growth hormone (GH)-releasing hormone-stimulated GH secretion in normal man. | Q41453744 | ||
| Biochemical mapping of the noradrenergic ventral bundle projection sites: Evidence for a noradrenergic-dopaminergic interaction | Q41729282 | ||
| Ventral tegmental area: site through which dopamine D2-receptor agonists evoke behavioural and electrocortical sleep in rats | Q42848461 | ||
| Modafinil as adjunct therapy for daytime sleepiness in obstructive sleep apnea | Q43806478 | ||
| Emerging views of dopamine in modulating sleep/wake state from an unlikely source: PD. | Q43882541 | ||
| Effect of ropinirole on sleep onset: a randomized, placebo-controlled study in healthy volunteers | Q43882559 | ||
| Polysomnographic characterization of pergolide-induced sleep attacks in idiopathic PD. | Q43882560 | ||
| Maintaining alertness and performance during sleep deprivation: modafinil versus caffeine | Q43893880 | ||
| Contributions of dopaminergic drugs and disease severity to daytime sleepiness in Parkinson disease | Q44022553 | ||
| Piribedil-induced sleep attacks in Parkinson's disease | Q44316809 | ||
| Randomized trial of modafinil for treating subjective daytime sleepiness in patients with Parkinson's disease | Q44351576 | ||
| Modafinil affects mood, but not cognitive function, in healthy young volunteers | Q44388070 | ||
| Sleep attacks, daytime sleepiness, and dopamine agonists in Parkinson's disease | Q44464242 | ||
| Spinal projections from the nucleus locus coeruleus and nucleus subcoeruleus in the cat and monkey as demonstrated by the retrograde transport of horseradish peroxidase | Q44774529 | ||
| The cognitive-enhancing properties of modafinil are limited in non-sleep-deprived middle-aged volunteers | Q44790167 | ||
| Benefits of adjunct modafinil in an open-label, pilot study in patients with schizophrenia | Q44848493 | ||
| Modafinil elicits sympathomedullary activation. | Q45309050 | ||
| Does modafinil activate the locus coeruleus in man? Comparison of modafinil and clonidine on arousal and autonomic functions in human volunteers. | Q46571142 | ||
| Pupil size and spontaneous pupillary waves associated with alertness, drowsiness, and sleep | Q47388903 | ||
| Functional magnetic resonance imaging neuroactivation studies in normal subjects and subjects with the narcoleptic syndrome. Actions of modafinil | Q48174375 | ||
| Daytime variations in central nervous system activation measured by a pupillographic sleepiness test | Q48697760 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | modafinil | Q410441 |
| P304 | page(s) | 756-770 | |
| P577 | publication date | 2006-01-09 | |
| P1433 | published in | Journal of Psychopharmacology | Q6295819 |
| P1476 | title | Comparison of pramipexole and modafinil on arousal, autonomic, and endocrine functions in healthy volunteers | |
| P478 | volume | 20 |
| Q48579808 | Arousal and the pupil: why diazepam-induced sedation is not accompanied by miosis. |
| Q79794456 | Comparison of pramipexole and amisulpride on alertness, autonomic and endocrine functions in healthy volunteers |
| Q30492844 | Comparison of pramipexole with and without domperidone co-administration on alertness, autonomic, and endocrine functions in healthy volunteers |
| Q33756951 | Convergent evidence for abnormal striatal synaptic plasticity in dystonia |
| Q30498393 | Drugs for sleep disorders: mechanisms and therapeutic prospects |
| Q34984936 | Effect of exercise training and dopamine agonists in patients with uremic restless legs syndrome: a six-month randomized, partially double-blind, placebo-controlled comparative study |
| Q60949840 | Functional Organization of the Sympathetic Pathways Controlling the Pupil: Light-Inhibited and Light-Stimulated Pathways |
| Q38114027 | Functional neuroanatomy of the central noradrenergic system |
| Q30489125 | Functional neuroanatomy of the noradrenergic locus coeruleus: its roles in the regulation of arousal and autonomic function part I: principles of functional organisation |
| Q24654140 | Functional neuroanatomy of the noradrenergic locus coeruleus: its roles in the regulation of arousal and autonomic function part II: physiological and pharmacological manipulations and pathological alterations of locus coeruleus activity in humans |
| Q42957021 | Impaired visuospatial associative memory and attention in obsessive compulsive disorder but no evidence for differential dopaminergic modulation |
| Q36982911 | Mapping anhedonia onto reinforcement learning: a behavioural meta-analysis |
| Q34546206 | Modafinil effects on behavior and oxidative damage parameters in brain of wistar rats. |
| Q34665871 | Modafinil: a review of neurochemical actions and effects on cognition |
| Q79888601 | Modulation of the acoustic startle response by the level of arousal: comparison of clonidine and modafinil in healthy volunteers |
| Q30497780 | Modulatory effects of modafinil on neural circuits regulating emotion and cognition |
| Q36905151 | Obstructive sleep apnea, hypertension, and wakefulness-promoting agents |
| Q37345319 | Pramipexole Increases Go Timeouts but Not No-go Errors in Healthy Volunteers |
| Q30487682 | Pramipexole effects on startle gating in rats and normal men |
| Q46979152 | Pupillography as a sensitive, noninvasive biomarker in healthy volunteers: first-in-man study of BAY 63-9044, a new 5-HT1A-receptor agonist with dopamine agonistic properties |
| Q36498715 | Single dose of a dopamine agonist impairs reinforcement learning in humans: behavioral evidence from a laboratory-based measure of reward responsiveness |
| Q64110848 | Standards in Pupillography |
| Q46979195 | The 5-min pupillary alertness test is sensitive to modafinil: a placebo controlled study in patients with sleep apnea. |
| Q37106827 | The potential role of dopamine D₃ receptor neurotransmission in cognition. |
| Q33519672 | Why do some promising brain-stimulation devices fail the next steps of clinical development? |
Search more.